(European Society of Cardiology) Patients with atrial fibrillation who need anticoagulation before undergoing electrical correction of their abnormal heartbeat (cardioversion) may benefit from treatment with edoxoban -- a non-vitamin K antagonist oral anticoagulant, according to results of the ENSURE-AF trial.
from EurekAlert! - Social and Behavioral Science http://ift.tt/2bzau33
No comments:
Post a Comment